These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 4949244)

  • 1. Residual cancer.
    Woodruff M
    Harvey Lect; 1971-1972; 66():161-76. PubMed ID: 4949244
    [No Abstract]   [Full Text] [Related]  

  • 2. Immunologic aspects of cancer.
    Sophocles AM; Nadler SH
    Surg Gynecol Obstet; 1971 Aug; 133(2):321-31. PubMed ID: 4935594
    [No Abstract]   [Full Text] [Related]  

  • 3. [Factors of bodily resistance and metastasis].
    Maĭskiĭ IN; Lomakin MS
    Usp Sovrem Biol; 1976; 82(4):63-76. PubMed ID: 790816
    [No Abstract]   [Full Text] [Related]  

  • 4. [Problems of the immunotherapy of malignant neoplasma].
    Trapeznikov NN; Iavorskiĭ VV
    Klin Med (Mosk); 1975 May; 52(5):15-22. PubMed ID: 1094178
    [No Abstract]   [Full Text] [Related]  

  • 5. [Immunology and cancer].
    Brunner KT
    Schweiz Med Wochenschr; 1973 Sep; 103(36):1249-52. PubMed ID: 4584090
    [No Abstract]   [Full Text] [Related]  

  • 6. [Tumor immunology].
    Cerni CM
    Subsid Med; 1974; 2():21-5. PubMed ID: 4606048
    [No Abstract]   [Full Text] [Related]  

  • 7. The concept of immunological surveillance against neoplasia.
    Möller G; Möller E
    Transplant Rev; 1976; 28():3-16. PubMed ID: 766327
    [No Abstract]   [Full Text] [Related]  

  • 8. [The immunology of cancer].
    Tabbara WS
    J Med Liban; 1971; 24(3):209-26. PubMed ID: 5151404
    [No Abstract]   [Full Text] [Related]  

  • 9. Tumor-specific immune mechanisms.
    Smith RT
    N Engl J Med; 1968 Jun; 278(24):1326-31 concl. PubMed ID: 4869875
    [No Abstract]   [Full Text] [Related]  

  • 10. Inhibition of subcutaneously growing line 1 carcinomas due to metastatic spread.
    Yuhas JM; Pazmiño NH
    Cancer Res; 1974 Aug; 34(8):2005-10. PubMed ID: 4366938
    [No Abstract]   [Full Text] [Related]  

  • 11. Tumor dormancy (a review).
    Alsabti EA
    Neoplasma; 1979; 26(3):351-61. PubMed ID: 394012
    [No Abstract]   [Full Text] [Related]  

  • 12. [Immunotherapy of neoplasms. Part I - Assumptions (author's transl)].
    Szmigiel Z; Skotnicki AB
    Przegl Lek; 1975; 32(5):460-5. PubMed ID: 50612
    [No Abstract]   [Full Text] [Related]  

  • 13. [Immunity in cancer].
    Seppälä M; Makela O
    Duodecim; 1970; 86(3):121-5. PubMed ID: 5447420
    [No Abstract]   [Full Text] [Related]  

  • 14. The nature of the immunological interaction between the host and the tumor.
    Alexander P
    Laryngoscope; 1975 Mar; 85(3):487-90. PubMed ID: 1121223
    [No Abstract]   [Full Text] [Related]  

  • 15. DC-based cancer vaccines: lessons from clinical trials.
    Brody JD; Engleman EG
    Cytotherapy; 2004; 6(2):122-7. PubMed ID: 15203988
    [No Abstract]   [Full Text] [Related]  

  • 16. Cancer and immunology.
    Curr Opin Immunol; 1989 Jun; 1(5):971-1051. PubMed ID: 2679747
    [No Abstract]   [Full Text] [Related]  

  • 17. [Why does a tumor grow?].
    Dosne Pasqualini C; Laguens RP; Colmerauer ME; Segal A
    Medicina (B Aires); 1974; 34(6):659-64. PubMed ID: 4617837
    [No Abstract]   [Full Text] [Related]  

  • 18. [Immunology of tumors].
    Clerici E
    Minerva Nefrol; 1983; 30(2 Suppl):13-8. PubMed ID: 6866320
    [No Abstract]   [Full Text] [Related]  

  • 19. Recurrent and metastatic malignant disease: immunological considerations.
    Carter RL
    Proc R Soc Med; 1974 Sep; 67(9):852-4. PubMed ID: 4610589
    [No Abstract]   [Full Text] [Related]  

  • 20. [Cytapheresis for autoadoptive immunotherapy of tumors].
    Borberg H; Abdallah A
    Beitr Infusionther Klin Ernahr; 1987; 18():254-60. PubMed ID: 3326584
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.